🇺🇸 FDA
Patent

US 9303042

Triazolothienopyrimidine compound inhibitors of urea transporters and methods of using inhibitors

granted A61KA61K31/519A61P

Quick answer

US patent 9303042 (Triazolothienopyrimidine compound inhibitors of urea transporters and methods of using inhibitors) held by The Regents of the University of California expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/519, A61P, A61P13/02, A61P13/12